The Marijuana Index™ moved lower last week, led by steep declines in CannaVEST Corp. (OTC: CANV) and modest declines in bellwethers like GW Pharmaceuticals plc (NASDAQ: GWPH) and MedBox Inc. (OTC: MDBX).

Top gainers included Cannabis Stevia Inc. (OTC: CBDS) with a 9% gain and BreedIT Corp. (OTC: BRDT) with a 7% gain for the week, as of Friday afternoon. Last week, CannabisFN featured a reporton BreedIT Corp. discussing the company’s business model and featuring a video interview with CEO Dr. Oded Sagee.

Cannabis regulatory initiatives also continued to move forward last week. Senators in Minnesota voted 48-18 to advance a bill that would make physician-prescribed medical cannabis legal, moving further than a House bill that would have been much more restrictive by limiting access to FDA-sanctioned clinical trials.

What's New?

● Affinor Resources Acquires Potential MMPR LP– Affinor Resources Inc. (OTC: RSSFF) announced that it entered an agreement to acquire 100% of a private company in the final stages of obtaining their MMPR license to grow medical marijuana in British Columbia, Canada.

● No Health Insurance Coverage for Cannabis… Yet– CannabisFN explores some of the regulatory hurdles surrounding health insurance coverage of medical cannabis, including the federal government’s tough stance and the time-consuming process of FDA-sanctioned clinical trials.

● SinglePoint Move to Corner Dispensary Signage Market– SinglePoint Inc. (OTC: SING) announced that it signed an LOI to acquire Drive Media Network LLC’s digital signage network with plans to introduce the product into cannabis dispensaries throughout the nation.

● Novus Targets Medical Cannabis Compliance– CannabisFN takes a look at Novus Acquisition & Development Corp. (OTC: NDEV) and its plans to capitalize on growth in the cannabis industry by developing compliance solutions for physicians, dispensaries, and patients.

● Medical Cannabis Legalization Moves Forward in MN– Minnesota Senators voted in favor of a bill that would make physician-prescribed medical cannabis legal for a broad range of patients, moving beyond a more restrictive bill that was introduced in the state’s House.

● BreedIT Corp: The Money is in the Seeds– CannabisFN explores BreedIT Corp.’s (OTC: BRDT) unique business model featuring an exclusive interview with CEO Dr. Oded Sagee, who discusses the company’s software, long-term goals, and potential play in licensing proprietary cannabis strains.

Exclusive Interview Series

In a recent episode of CannabisFN’s Executive Interview Series, we talked to CEO and Director of BreedIT Corp. Dr. Oded Sagee. Dr. Sagee discusses the company’s unique software that was developed by a team of the world’s leading breeding specialists and how it could impact the cannabis industry.

Click Here: Watch the Full Interview

What to Watch This Week

The cannabis sector moved lower last week as investors tempered their expectations. While many stocks in the space appear lofty, some companies present unique opportunities to profit over the long-term. The stabilization of valuations should help form a base for less volatile price action and more opportunities for longer term investors to become involved rather than short term traders.

Upcoming Events

· WeedStock Conference– June 29 to July 1, 2014 – The 1st Annual Cannabis Investor Conference in Denver, Colorado will feature networking events, industry speakers, expert panels, and more.

About CannabisFN

CannabisFN.com is a dedicated financial network covering new, emerging and established companies operating in the burgeoning multi-billion dollar medical marijuana (“MMJ”) and cannabis industries. CannabisFN’s coverage is syndicated on the leading industry specific and mainstream financial websites and social media. To learn more and request a media kit, visit http://www.cannabisfn.com/market-defining-companies-program/.

To subscribe to the CannabisFN newsletter or read additional coverage on cannabis laws and investments, visit http://www.cannabisfn.com.

Cannabis Financial Network is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. All information that we provide is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Furthermore, investing in such securities involves substantial risk of loss and investors should seek advice from financial professionals before investing. CFN may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. View Full Disclaimer

Comments

Novus Acquisition & Dev Stock News

News

Latest Novus Acquisition & Dev Stock News | OTC:NDEV | Benzinga

Tuesday, May 13, 2014

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell